Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/04/2000 | WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
05/04/2000 | WO2000024889A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip |
05/04/2000 | WO2000024888A1 CDNA SEQUENCE AND GENOMIC ORGANIZATION FOR A 59.4 KDA NEURONAL-SPECIFIC 7 TRANSMEMBRANE PROTEIN (pNEU60) |
05/04/2000 | WO2000024887A2 Method for biotechnological production of ligand binding, especially extracellular, fragments of receptor subunits, especially neuroreceptors and hormone receptors |
05/04/2000 | WO2000024886A1 Prv-1 gene and the use thereof |
05/04/2000 | WO2000024885A2 p53 MORPHOLINO-BASED ANTISENSE |
05/04/2000 | WO2000024884A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
05/04/2000 | WO2000024883A1 Constructing and screening a dna library of interest in filamentous fungal cells |
05/04/2000 | WO2000024882A1 Method for generating a gene library |
05/04/2000 | WO2000024881A1 Gene trap vectors |
05/04/2000 | WO2000024880A1 Transgenic c. elegans as a model organism for research into alzheimer's disease |
05/04/2000 | WO2000024879A1 Endoglucanases and cellulase preparations containing the same |
05/04/2000 | WO2000024878A2 Mutant luciferase having increased thermostability |
05/04/2000 | WO2000024876A2 Spumavirus isolated from humans |
05/04/2000 | WO2000024874A1 Recombinant extracellular chitinases and uses thereof |
05/04/2000 | WO2000024873A1 Process for recovering heterologous polypeptides from bacterial cells |
05/04/2000 | WO2000024871A2 Kv BETA 1.1-DEFICIENT MICE WITH IMPAIRED LEARNING |
05/04/2000 | WO2000024868A2 Rapid recovery of shoots through thin stem slices after preconditioning of micropropagated fruit tree shoots |
05/04/2000 | WO2000024867A2 Plant histidine biosynthetic enzymes |
05/04/2000 | WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents |
05/04/2000 | WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies |
05/04/2000 | WO2000024780A2 Compositions and methods for treating polycystic kidney disease |
05/04/2000 | WO2000024779A1 Lysine-rich statherin protein |
05/04/2000 | WO2000024776A1 Novel toll-like receptor and gene thereof |
05/04/2000 | WO2000024775A1 Gene cluster involved in nogalamycin biosynthesis, and its use in production of hybrid antibiotics |
05/04/2000 | WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host |
05/04/2000 | WO2000024772A2 Scorpion toxins |
05/04/2000 | WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
05/04/2000 | WO2000024770A2 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
05/04/2000 | WO2000024769A2 Process for recovering heterologous polypeptide from bacterial refractile particles |
05/04/2000 | WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
05/04/2000 | WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | WO2000024759A1 Systemic delivery of gene products via skin |
05/04/2000 | WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF |
05/04/2000 | WO2000024755A1 Ovary-specific genes and proteins |
05/04/2000 | WO2000024754A1 infB POLYPEPTIDE AND POLYNUCLEOTIDES OF STREPTOCOCCUS PNEUMONIAE |
05/04/2000 | WO2000024606A1 A coupling mechanism for a frameless trailer |
05/04/2000 | WO2000024426A1 Ribozymes used as prodrugs |
05/04/2000 | WO2000024415A2 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
05/04/2000 | WO2000024412A2 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
05/04/2000 | WO2000024408A1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
05/04/2000 | WO2000024404A1 Thio-modified aptamer synthetic methods and compositions |
05/04/2000 | WO2000024254A1 Compositions and methods for modulating expression within smooth muscle cells |
05/04/2000 | WO2000024249A2 Compositions comprising plant cell growth regulating compounds and methods of use thereof |
05/04/2000 | WO2000024246A2 Transgenic fish carrying plasmid for mutation detection and methods |
05/04/2000 | WO2000024244A1 New plants formed by microparticle bombardment with uncharacterised dna |
05/04/2000 | WO2000014255A8 REGULATION OF GENE EXPRESSION THROUGH MANIPULATION OF mRNA SPLICING AND ITS USES |
05/04/2000 | WO2000012741A3 Inducible expression system |
05/04/2000 | WO2000012139B1 Hypoxia regulated genes |
05/04/2000 | WO2000008169A8 Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
05/04/2000 | WO2000007038A3 Protein fragment complementation assays |
05/04/2000 | WO2000006751A3 Repressor proteins producing cell lines for the propagation of vectors |
05/04/2000 | WO2000006750A3 Method for autoactivation of procaspase 8 |
05/04/2000 | WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | WO2000006733A3 T cell receptor proteins, nucleic acid molecules, and uses thereof |
05/04/2000 | WO2000006732A3 Polynucleotide encoding an autoantigen associated with endometriosis |
05/04/2000 | WO2000006730A3 Human cytoskeletal proteins |
05/04/2000 | WO2000006728A3 Phosphorylation effectors |
05/04/2000 | WO2000006727A3 Human epidermal proteins hepi-1 to hepi-6 |
05/04/2000 | WO2000006706A3 Map kinase phosphatase mutant |
05/04/2000 | WO2000006705A3 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
05/04/2000 | WO2000006204A3 Genetically engineered cells and tissues |
05/04/2000 | WO2000005381A3 Expression of enzymes involved in cellulose modification |
05/04/2000 | WO2000005367A3 Human proteins having hydrophobic domains and dnas encoding these proteins |
05/04/2000 | WO2000005353A3 Chorismate synthase from plants |
05/04/2000 | WO2000003009A3 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use |
05/04/2000 | WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions |
05/04/2000 | WO2000002909A3 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
05/04/2000 | WO2000002897B1 Delta cleavage products and methods based thereon |
05/04/2000 | WO2000001842A3 Screening of hydrolase libraries for enantioselective enzymes |
05/04/2000 | WO2000000614A3 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) |
05/04/2000 | WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
05/04/2000 | WO1999066959A3 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
05/04/2000 | WO1999066036A9 Transplants for myocardial scars |
05/04/2000 | WO1999062315A3 Method for altering the activity of proteins of the pka signaling pathway |
05/04/2000 | WO1999061619A8 Cell cycle genes, proteins and uses thereof |
05/04/2000 | WO1999061580A8 Modification of cereal grain hardness via expression of puroindoline proteins |
05/04/2000 | WO1999061066A3 Convection-enhanced delivery of aav vectors |
05/04/2000 | WO1999060165A9 Chemically assembled nano-scale devices |
05/04/2000 | WO1999060146A9 Adeno-associated virus vectors and uses thereof |
05/04/2000 | WO1999054474A3 Bacterial yiha polypeptide family |
05/04/2000 | WO1999053021A9 Cell differentiation/proliferation and maintenance factor and uses thereof |
05/04/2000 | WO1999052944A8 G-protein coupled receptors |
05/04/2000 | WO1999051781A9 Hepatitis c virus ns5b compositions and methods of use thereof |
05/04/2000 | WO1999047660A9 Retroviral packaging cell line |
05/04/2000 | WO1999045155A3 Oligonucleotides for the amplification and detection of epstein barr virus (ebv) nucleic acid |
05/04/2000 | DE19856882C1 New spermatogenesis protein useful for investigation and modulation of spermatogenesis, particularly for diagnosis and treatment of spermatogenesis disorders |
05/04/2000 | DE19850680A1 Verfahren zur Bestimmung der Reparaturkapazität von DNS-Reparaturenzyme enthaltenden Lösungen und zum Nachweis von DNS-Strukturmodifikationen und Basenfehlpaarungen Method for determining the capacity of repair DNA repair enzymes containing solutions and for the detection of DNA-structure modifications and base mismatches |
05/04/2000 | DE19850429A1 Fragmente Fragments |
05/04/2000 | DE19850242A1 Konstruktion von Produktionsstämmen für die Herstellung von substituierten Phenolen durch gezielte Inaktivierung von Genen des Eugenol- und Ferulasäure-Katabolismus Construction of production strains for the preparation of substituted phenols by targeted inactivation of genes of eugenol and ferulic acid catabolism |
05/04/2000 | DE19850015A1 Proteine der Stomatinfamilie und ihre Verwendung als Zielproteine für die Schm erztherapie Erztherapie proteins of the Stomatinfamilie and their use as target proteins for jewelry |
05/04/2000 | DE19849643A1 An das AAV-Kapsid bindender, den Zelltropismus verändernder Antikörper und Verfahren zum gerichteten Gentransfer At the AAV capsid binding, cell tropism changing antibodies and methods for directed gene transfer |
05/04/2000 | DE19835910C1 Gen isoliert auf dem kurzen Arm des menschlichen Chromosoms 17 Gene isolated on the short arm of human chromosome 17 |
05/04/2000 | CA2771000A1 Processes and means for the isolation and purification of nucleic acids at surfaces |
05/04/2000 | CA2356595A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip |
05/04/2000 | CA2349211A1 Prv-1 gene and the use thereof |
05/04/2000 | CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | CA2348839A1 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
05/04/2000 | CA2348838A1 Improved aav vector production |
05/04/2000 | CA2348837A1 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns |